| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ImageneBio, Inc. | Chief Financial Officer | Common Stock | 11.1K | $191K | $17.16 | Jul 28, 2025 | Direct |
| Aptose Biosciences Inc. | Senior VP, CFO, and CBO | Employee Stock Option | 600K | Jan 18, 2022 | Direct | ||
| ImageneBio, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 0 | Jul 25, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IMA | ImageneBio, Inc. | Jul 25, 2025 | 5 | -$79.5K | 4 | Jul 29, 2025 | Chief Financial Officer |
| IKNA | Ikena Oncology, Inc. | Feb 1, 2024 | 1 | $0 | 4 | Feb 2, 2024 | CFO & Head of Corp. Dev. |
| IKNA | Ikena Oncology, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | CFO & Head of Corp. Dev. |
| IKNA | Ikena Oncology, Inc. | Apr 25, 2022 | 1 | $0 | 4 | Apr 25, 2022 | CFO & Head of Corp. Dev. |
| IKNA | Ikena Oncology, Inc. | Apr 25, 2022 | 0 | $0 | 3 | Apr 25, 2022 | CFO & Head of Corp. Dev. |
| APTO | Aptose Biosciences Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 20, 2022 | Senior VP, CFO, and CBO |
| APTO | Aptose Biosciences Inc. | Aug 19, 2021 | 2 | $0 | 4 | Aug 23, 2021 | Senior VP, CFO, and CBO |